Plant-powered therapies, delivered by nature.

EI. Ventures’ Psilly is on its way to becoming the world’s leading source for therapy powered by nature. We are building a community and educational platform around the use of functional and psychedelic mushrooms to address a growing mental health crisis.

Learn More

As Seen In

Our Mission

We are building the natural psychedelics movement that is open-sourced to the world. Our team of scientists, healers, and conscious investors are changing the narrative around psychedelic therapy so that our gold-standard treatment technology and delivery system can move through FDA trials towards legalization. We want to provide people with a safer and more efficient path to self-improvement so that they can overcome challenges and move forward with higher levels of self-acceptance and a more attuned perspective.

Mental health is an epidemic and worldwide crisis—and the answer isn't pharmaceuticals. It's farmaceuticals. Through increasing educational resources on natural psychedelic therapies and the path towards legalization, we will share Psilly with everyone in need, regardless of their financial position.

FDA-Regulated Psychedelic Therapies

Plant-based Wellness Products

Web3 Solution to Mental Health

Resources

Survey Monkey

Momentive study: psychedelics

View Resource

National Institute of Mental Health

Psychedelics as Therapeutics: Gaps, Challenges and Opportunities

View Resource

Nature

Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreat

View Resource

Johns Hopkins

Psychedelics Research and Psilocybin Therapy

View Resource

National Institutes of Health

The Therapeutic Potential of Psilocybin

View Resource

Psilly is in the Metaverse

Come say hello in the Sandbox.

Coming Soon

Our Story

We started our journey over 12 years ago in Los Angeles, bringing healing modalities to a growing community of individuals curious about alternative paths to health and wellness. Then came the island of Maui, Hawaii, where we connected with farmers, chemists, and iconic leaders of psychedelic medicine to explore the power of the plant and natural therapies that unlock the mind and heal the soul. Psilly, a continuation of Orthogonal Thinker and EI. Ventures’ mission of conscious, sustainable investing and community building, was born in 2021.

Road to FDA Approval

Stage 01

Research and Development

Formulation and optimization of Psilly Patch for transdermal delivery.

Stage 02

Pre-Clinical Development

Pre-clinical development of Psilly Patch for compatibility, skin-sensitivity, and transdermal delivery of Psilocin.

Stage 03

Phase 1 Clinical Trials

Dose-escalation and optimization for safety and tolerability.

Stage 04

Phase 2b/3 Clinical Trials

For safety and efficacy of Psilly Patch.

Stage 05

Phase 3 Pivotal Global Clinical Trials

For safety, efficacy, and tolerability of Psilly Patch.

Stage 01

Research and Development

Formulation and optimization of Psilly Patch for transdermal delivery.

Stage 02

Pre-Clinical Development

Pre-clinical development of Psilly Patch for compatibility, skin-sensitivity, and transdermal delivery of Psilocin.

Stage 03

Phase 1 Clinical Trials

Dose-escalation and optimization for safety and tolerability.

Stage 04

Phase 2b/3 Clinical Trials

For safety and efficacy of Psilly Patch.

Stage 05

Phase 3 Pivotal Global Clinical Trials

For safety, efficacy, and tolerability of Psilly Patch.

@psill.y